Japanese company announced the development of Ebola drugs

Source: taiwan.com.cn on November 13, 2014, Fuji film holding company announced on November 11, 2014 that the influenza treatment drug "avigav" (transliteration, avigan) developed by its subsidiary company may be internationally certified as Ebola haemorrhagic fever treatment drug as soon as January next year, becoming the first certified anti Ebola drug in the world Fuji film said that France and Guinea will start the clinical trial of "fapiravir" in Guinea from mid November, and the results are expected by the end of December Due to the emergency, the relevant agencies will complete the review of the safety and effectiveness of "fapiravir" within one month If certified, Fuji film plans to provide "fapiravir" through the Japanese government to countries in West Africa where the Ebola epidemic is raging, and to other countries and regions if necessary "Fapiravir" is a flu treatment drug developed by Fuji film's "Fushan chemical industry company" It just obtained production and sales license in Japan in March this year "Fabiravir" is an effective drug against Ebola, said gusen Chonglong, chairman of Fujifilm.